ONFO:NASDAQOnfolio Holdings Inc. Analysis
Data as of 2026-06-13 - not real-time
$0.35
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Onfolio Holdings (ONFO) is trading at $0.3538, well below its DCF fair value of $5.18 and the 20‑day SMA of $0.592, indicating severe price compression. The stock sits near its technical support level of $0.3231 with a bearish MACD (‑0.154 vs signal ‑0.134) and an RSI of 18.5, suggesting oversold conditions but also a lack of buying pressure. Recent news confirms a 34% YoY revenue decline to $1.9 M for Q1 2026, even as management highlights cost cuts and an acquisition program targeting $5‑10 M of assets. Fundamental metrics are weak: negative gross (57.6%) and operating margins (‑44.6%), a debt‑to‑equity ratio of 206, and a max drawdown of ‑76%, underscoring financial distress. Volatility is extreme at ~92% over 30 days and beta is high at 1.78, amplifying market‑risk exposure. Despite these challenges, the company’s cash position ($0.84 M) and a strategic focus on cash‑generative online businesses provide a modest runway.
The valuation gap suggests the stock is undervalued from a pure price‑target perspective, yet the deteriorating earnings profile and high liquidity risk temper optimism. Short‑term momentum is negative, but the announced acquisition pipeline could improve top‑line growth if executed efficiently. Investors should weigh the upside of a potential turnaround against the high probability of further price erosion given the current financial fragility. Overall, the outlook remains cautious, with any upside hinging on successful acquisitions and sustained cost reductions.
The valuation gap suggests the stock is undervalued from a pure price‑target perspective, yet the deteriorating earnings profile and high liquidity risk temper optimism. Short‑term momentum is negative, but the announced acquisition pipeline could improve top‑line growth if executed efficiently. Investors should weigh the upside of a potential turnaround against the high probability of further price erosion given the current financial fragility. Overall, the outlook remains cautious, with any upside hinging on successful acquisitions and sustained cost reductions.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish MACD and RSI indicating continued downtrend
- Price below 20‑day SMA and near support level
- High volatility and beta amplifying price swings
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside from announced $5‑10 M acquisition program
- Significant valuation discount to DCF fair value
- Ongoing cash‑flow constraints and negative earnings
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Long‑term undervaluation relative to intrinsic fair value
- Strategic focus on cash‑generative internet assets
- Possibility of a turnaround if cost reductions and acquisitions succeed
Key Metrics & Analysis
Financial Health
Revenue Growth-33.60%
Profit Margin-44.10%
ROE-138.69%
ROA-15.80%
Debt/Equity206.14
P/B Ratio-14.7
Op. Cash Flow$-1636603
Free Cash Flow$2.7M
Industry P/E17.0
Technical Analysis
TrendNeutral
RSI18.5
Support$0.32
Resistance$1.04
MA 20$0.59
MA 50$0.88
MA 200$0.85
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$5.18
GradeUndervalued
TypeValue
Risk Assessment
Beta1.79
Volatility91.98%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.